Ignite Creation Date:
2024-05-06 @ 2:25 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04318223
Status:
UNKNOWN
Last Update Posted:
2020-03-23
First Post:
2019-12-02
Brief Title:
Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK46 Inhibitor in Combination With Hormonal Therapy
Sponsor:
Consorzio Oncotech
Organization:
Consorzio Oncotech